The medical device business landscape is changing rapidly in response to a wide range of socioeconomic and government pressures. As the U.S. population continues to age, by 2030 20% of U.S. residents will be over 65, compared with 13% in 2010 and 9.8% in 1970, the demand for better and more cost-effective medical care is becoming more acute.
Home » Bridging the innovation gap
More recent news
- FDA says Medtronic can study Affera pulsed field ablation system for treating ventricular tachycardia
- Analysts see $400B BCI opportunity
- Endostart wins CE mark to bring magnetic balloon tech to enteroscopy
- Neurotech company CeriBell prices $180.3M IPO
- Astellas subsidiary Iota wins FDA IDE nod to study implantable bladder device